Home › Funds › RA CAPITAL MANAGEMENT, L.P. › AKTS

RA CAPITAL MANAGEMENT, L.P. position in AKTS

AKTIS ONCOLOGY INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 1,314,405 shares of AKTS (AKTIS ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$42.4M, representing 0.37% of its reported portfolio and ranking #44 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed AKTS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.31M sh
Reported value held$42.36M
Portfolio Weight0.37%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s AKTS position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in AKTS in Q1 2026 at 1,503,084 shares (US$26.9M). The position peaked in Q2 2026 at 1,314,405 shares, worth US$42.4M. Across 2 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,314,405 shares valued at US$42.4M — a reduction of -188,679 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.50M $26.89M New
Q2 2026 1.31M $42.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AKTS and 13F data

AKTS (AKTIS ONCOLOGY INC) is a Health Care company. 121 other funds we track also report a position in AKTS — the largest reported positions include MPM BioImpact LLC (US$155.9M), EcoR1 Capital, LLC (US$155.5M), Blue Owl Capital Holdings LP (US$99.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AKTS

All AKTS fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held AKTS?

RA CAPITAL MANAGEMENT, L.P. has disclosed AKTS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in AKTS?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 1.31M shares of AKTS (AKTIS ONCOLOGY INC), valued at $42.36M, representing 0.37% of its reported portfolio and ranking #44.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling AKTS?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in AKTS. The position peaked in Q2 2026 at 1.31M shares.

Which other funds hold AKTS?

Other major institutional holders of AKTS include MPM BioImpact LLC, EcoR1 Capital, LLC, Blue Owl Capital Holdings LP, among 121 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.